BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,279,493 | -17.0% | 86,897 | +0.2% | 0.05% | -14.5% |
| Q2 2023 | $3,949,915 | +8.7% | 86,697 | -3.2% | 0.06% | +3.8% |
| Q1 2023 | $3,634,054 | -20.1% | 89,597 | +0.4% | 0.05% | -26.4% |
| Q4 2022 | $4,546,371 | -6.0% | 89,197 | -0.7% | 0.07% | -11.1% |
| Q3 2022 | $4,837,000 | -16.0% | 89,797 | +0.2% | 0.08% | -12.0% |
| Q2 2022 | $5,755,000 | -17.2% | 89,597 | 0.0% | 0.09% | 0.0% |
| Q1 2022 | $6,947,000 | -11.3% | 89,597 | -1.8% | 0.09% | -5.2% |
| Q4 2021 | $7,828,000 | +7.0% | 91,197 | +0.2% | 0.10% | -2.0% |
| Q3 2021 | $7,319,000 | -5.1% | 90,997 | -5.0% | 0.10% | 0.0% |
| Q2 2021 | $7,712,000 | -6.5% | 95,797 | -2.0% | 0.10% | -13.9% |
| Q1 2021 | $8,248,000 | +0.7% | 97,797 | -4.2% | 0.12% | -0.9% |
| Q4 2020 | $8,192,000 | +4.3% | 102,097 | +4.5% | 0.12% | -10.8% |
| Q3 2020 | $7,857,000 | -6.0% | 97,697 | +0.6% | 0.13% | -15.0% |
| Q2 2020 | $8,360,000 | +11.9% | 97,097 | +5.5% | 0.15% | -5.6% |
| Q1 2020 | $7,469,000 | -2.9% | 91,997 | 0.0% | 0.16% | +20.0% |
| Q4 2019 | $7,692,000 | -4.1% | 91,997 | +0.3% | 0.14% | -11.8% |
| Q3 2019 | $8,021,000 | +6.3% | 91,697 | -0.4% | 0.15% | +6.2% |
| Q2 2019 | $7,543,000 | -1.8% | 92,097 | -2.5% | 0.14% | -5.3% |
| Q1 2019 | $7,679,000 | +25.1% | 94,440 | +1.2% | 0.15% | +9.4% |
| Q4 2018 | $6,140,000 | -14.4% | 93,296 | +0.2% | 0.14% | 0.0% |
| Q3 2018 | $7,177,000 | +5.0% | 93,096 | +0.5% | 0.14% | -2.1% |
| Q2 2018 | $6,837,000 | +13.3% | 92,596 | -0.2% | 0.14% | +10.9% |
| Q1 2018 | $6,035,000 | +0.7% | 92,796 | +0.1% | 0.13% | +1.6% |
| Q4 2017 | $5,992,000 | +4.4% | 92,696 | +1.3% | 0.13% | -2.3% |
| Q3 2017 | $5,741,000 | +3.8% | 91,496 | +0.1% | 0.13% | 0.0% |
| Q2 2017 | $5,533,000 | +16.9% | 91,396 | +0.1% | 0.13% | +14.2% |
| Q1 2017 | $4,735,000 | +17.0% | 91,296 | 0.0% | 0.11% | +10.8% |
| Q4 2016 | $4,048,000 | -6.7% | 91,296 | +0.1% | 0.10% | -8.9% |
| Q3 2016 | $4,341,000 | +5.4% | 91,196 | +0.1% | 0.11% | +1.8% |
| Q2 2016 | $4,119,000 | +2.6% | 91,096 | -6.8% | 0.11% | +0.9% |
| Q1 2016 | $4,013,000 | +7.8% | 97,696 | +0.1% | 0.11% | +7.9% |
| Q4 2015 | $3,723,000 | +16.3% | 97,596 | +0.2% | 0.10% | +9.8% |
| Q3 2015 | $3,200,000 | -52.8% | 97,396 | +0.5% | 0.09% | -48.9% |
| Q2 2015 | $6,776,000 | +2.0% | 96,896 | -0.1% | 0.18% | +2.9% |
| Q1 2015 | $6,644,000 | -3.4% | 96,996 | +3.3% | 0.18% | -7.4% |
| Q4 2014 | $6,881,000 | +2.1% | 93,896 | 0.0% | 0.19% | -2.1% |
| Q3 2014 | $6,739,000 | -0.9% | 93,896 | -0.2% | 0.19% | -1.0% |
| Q2 2014 | $6,803,000 | -5.0% | 94,096 | -3.3% | 0.20% | -5.3% |
| Q1 2014 | $7,159,000 | +6.5% | 97,296 | +0.6% | 0.21% | +3.5% |
| Q4 2013 | $6,725,000 | +5.9% | 96,696 | 0.0% | 0.20% | -3.4% |
| Q3 2013 | $6,352,000 | -5.9% | 96,696 | -0.8% | 0.21% | -9.6% |
| Q2 2013 | $6,753,000 | – | 97,496 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |